Reporting tumor deposits in colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how doctors report tumor deposits (small clusters of cancer cells) in rectal cancer. It compares older and newer staging systems to improve treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rectal cancer (confirmed by biopsy)
- You had surgery to remove the tumor between January 2007 and December 2017, or between January 2022 and December 2024
- Your MRI and pathology reports are still available
- You are 16 years old or older
- You do not have cancer that has spread to other parts of the body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an MRI scan done during chemoradiation can help doctors track how rectal cancer treatment is working. It may improve how they measure response early so treatment planning can be better tailored.
This study looks at how well cancer found on scans matches the actual cancer seen under the microscope after surgery. It may help improve how doctors plan treatment for colon, sigmoid, or rectal adenocarcinoma.
This trial is looking at how to improve the diagnosis and treatment of rectal cancer by reviewing MRI scans and reports. It may help doctors make better treatment decisions for people with this type of cancer.
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
This trial analyzes biological and clinical information from people who have had surgery for rectal cancer since 2019. It aims to better understand rectal tumors, which may help improve future treatments.
This study uses a special MRI to help understand and stage colorectal cancer that has come back in the pelvis. The goal is to improve how doctors make treatment decisions after previous surgery.
Hear when a new Rectal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.